SOUTH
PLAINFIELD, N.J., June 2, 2023
/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today
announced that the company will present a company overview at the
following conferences:
Jefferies Healthcare Conference
Wednesday, June 7 at 12:30 p.m. EDT
Goldman Sachs 44th Annual Global
Healthcare Conference
Wednesday,
June 14 at 1:40 p.m.
EDT/10:40 a.m. PDT
The presentations will be webcast live on the Events and
Presentations page under the Investor section of PTC Therapeutics'
website at https://ir.ptcbio.com/events-presentations and will be
archived for 30 days following the presentations. It is recommended
that users connect to PTC's website several minutes prior to the
start of the webcast to ensure a timely connection.
About PTC Therapeutics, Inc.
PTC is a science-driven,
global biopharmaceutical company focused on the discovery,
development and commercialization of clinically differentiated
medicines that provide benefits to patients with rare disorders.
PTC's ability to globally commercialize products is the foundation
that drives investment in a robust and diversified pipeline of
transformative medicines and our mission to provide access to
best-in-class treatments for patients who have an unmet medical
need. The company's strategy is to leverage its strong scientific
expertise and global commercial infrastructure to maximize value
for its patients and other stakeholders. To learn more about PTC,
please visit us at www.ptcbio.com and follow us on Instagram,
Facebook, Twitter, and LinkedIn.
For More Information:
Investors:
Kylie
O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com
Media:
Jeanine
Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-301840729.html
SOURCE PTC Therapeutics, Inc.